Latest
Hilbert Raises $28M Series A to Connect Enterprise Data With Agentic AI DecisioningHilbert Raises $28M Series A to Connect Enterprise Data With Agentic AI Decisioning|Timeshifter Raises New Funding to Scale Jet Lag and Circadian Health PlatformTimeshifter Raises New Funding to Scale Jet Lag and Circadian Health Platform|Terremoto Biosciences Raises $108M Series C to Advance Covalent Small-Molecule MedicinesTerremoto Biosciences Raises $108M Series C to Advance Covalent Small-Molecule Medicines|Keebler Health Raises $16M Series A to Turn Unstructured Clinical Data Into Value-Based Care InsightsKeebler Health Raises $16M Series A to Turn Unstructured Clinical Data Into Value-Based Care Insights|Gitar Raises $9M to Build AI Agents for Code Review and Continuous IntegrationGitar Raises $9M to Build AI Agents for Code Review and Continuous Integration|HockeyStack Raises New Funding to Expand AI Revenue Agents for Enterprise GTM TeamsHockeyStack Raises New Funding to Expand AI Revenue Agents for Enterprise GTM Teams|NanoTech Materials Raises $29.4M Series A to Scale Heat and Fire Protection CoatingsNanoTech Materials Raises $29.4M Series A to Scale Heat and Fire Protection Coatings|HYFIX Raises $15M Seed to Build Autonomous Systems Chips for Drones and RoboticsHYFIX Raises $15M Seed to Build Autonomous Systems Chips for Drones and Robotics|Turion Space Raises $75M+ Series B to Expand Orbital Intelligence and Space Infrastructure PlatformTurion Space Raises $75M+ Series B to Expand Orbital Intelligence and Space Infrastructure Platform|Contoro Secures Strategic Investment as Warehouse Robotics Automation Gains MomentumContoro Secures Strategic Investment as Warehouse Robotics Automation Gains Momentum|Hilbert Raises $28M Series A to Connect Enterprise Data With Agentic AI DecisioningHilbert Raises $28M Series A to Connect Enterprise Data With Agentic AI Decisioning|Timeshifter Raises New Funding to Scale Jet Lag and Circadian Health PlatformTimeshifter Raises New Funding to Scale Jet Lag and Circadian Health Platform|Terremoto Biosciences Raises $108M Series C to Advance Covalent Small-Molecule MedicinesTerremoto Biosciences Raises $108M Series C to Advance Covalent Small-Molecule Medicines|Keebler Health Raises $16M Series A to Turn Unstructured Clinical Data Into Value-Based Care InsightsKeebler Health Raises $16M Series A to Turn Unstructured Clinical Data Into Value-Based Care Insights|Gitar Raises $9M to Build AI Agents for Code Review and Continuous IntegrationGitar Raises $9M to Build AI Agents for Code Review and Continuous Integration|HockeyStack Raises New Funding to Expand AI Revenue Agents for Enterprise GTM TeamsHockeyStack Raises New Funding to Expand AI Revenue Agents for Enterprise GTM Teams|NanoTech Materials Raises $29.4M Series A to Scale Heat and Fire Protection CoatingsNanoTech Materials Raises $29.4M Series A to Scale Heat and Fire Protection Coatings|HYFIX Raises $15M Seed to Build Autonomous Systems Chips for Drones and RoboticsHYFIX Raises $15M Seed to Build Autonomous Systems Chips for Drones and Robotics|Turion Space Raises $75M+ Series B to Expand Orbital Intelligence and Space Infrastructure PlatformTurion Space Raises $75M+ Series B to Expand Orbital Intelligence and Space Infrastructure Platform|Contoro Secures Strategic Investment as Warehouse Robotics Automation Gains MomentumContoro Secures Strategic Investment as Warehouse Robotics Automation Gains Momentum
Back to articles
Jesse Landry

Coral Care Secures $13M Series A Funding for In-Home Pediatric Therapy Platform

Coral Care just pulled in $13M in Series A capital, and this one hits different. Because this is not some abstract SaaS optimizing ad clicks. This is what happens when a parent runs into a wall in...

Funding Details

Amount

$13M

Round

Series A

Coral Care just pulled in $13M in Series A capital, and this one hits different. Because this is not some abstract SaaS optimizing ad clicks. This is what happens when a parent runs into a wall in the healthcare system and decides the wall is the problem.

Founded in 2023, Coral Care is the brainchild of Jennifer Wirt, Founder & CEO, who built the company after navigating developmental delays with her own daughter and running headfirst into waitlists, insurance friction, and the slow grind of “maybe next quarter.” Instead of accepting the bottleneck, Jennifer Wirt engineered a release valve. In-home pediatric speech, occupational, and physical therapy delivered by licensed clinicians. Access without the maze.

Haymaker Ventures led the $13M Series A, joined by FCA Ventures, Peterson Ventures, AlleyCorp, Reach Capital, Jefferson River Capital, Greymatter Capital, Mother Ventures, and Charge Ventures. That is a serious table of capital allocators who know the difference between a trend and a tectonic shift. When that many disciplined investors lean in, it is not charity. It is conviction.

Coral Care now operates across multiple states, with expansion into Dallas, Houston, Philadelphia, and Pittsburgh. The network includes more than 400 licensed pediatric therapists. More than 75% of families continue care beyond 4 months. Clinicians reclaim up to 15 hours a week by offloading scheduling, documentation, billing, and credentialing to Coral Care’s proprietary platform. Time is the only currency that compounds for everyone in this equation, and Coral Care is printing it responsibly.

Let’s talk business mechanics. Coral Care is not trying to digitize empathy. It is operationalizing access. The model is clean: families get vetted, insurance-supported, in-home care; clinicians get infrastructure without drowning in admin; investors get exposure to a category where demand is painfully real and supply has historically been fragmented. The company’s earlier capital, approximately $6.5M, set the foundation. This $13M pours concrete.

The play on words is almost too easy. Coral reefs are ecosystems. They thrive when every organism has a role and the water is clear. Coral Care is building its own reef in pediatric therapy, aligning families, clinicians, and capital into a living system that grows stronger with density. Scale here is not vanity. It is access.

Congratulations to Jennifer Wirt, Founder & CEO, and the entire Coral Care team for building something that respects both the child in the living room and the clinician on the calendar. And credit to Haymaker Ventures and the full investor syndicate for recognizing that sometimes the most disruptive thing in tech is not another app notification, but a knock on the door from a licensed therapist who finally had the time to show up.